Private Market View

Biobot Analytics

Cambridge, MA · Founded 2017 · Privately Held (backing)

Last price · $/share
Implied valuation
$126.8M
Total raised
$41.2M
Last round
Early Stage VC
May 2025
What is Biobot Analytics worth?
$126.8Mlast known valuation

Biobot Analytics last raised $13.5M in its Early Stage VC (May 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 38 names
  • ·Watchlist + deal alerts for Biobot Analytics
Create free account
No card required

Funding history

3 rounds
DateRoundRaisedPost-money
May 2025Early Stage VC$13.5M
Jul 2021Early Stage VC$20.8M
Apr 2020Early Stage VC$6.7M

How Biobot Analytics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Biobot Analytics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Biobot Analytics worth?
Biobot Analytics's last known valuation is $126.8M.
How much has Biobot Analytics raised?
Biobot Analytics has raised $41.2M in total funding across 3 recorded rounds.
When did Biobot Analytics last raise?
Biobot Analytics last raised in May 2025 (Early Stage VC), raising $13.5M.